Literature DB >> 15005786

Higher activity by opaque endometriotic lesions than nonopaque lesions.

Khaleque Newaz Khan1, Hideaki Masuzaki, Akira Fujishita, Michio Kitajima, Ichiro Sekine, Tadayuki Ishimaru.   

Abstract

BACKGROUND: Higher activity by early endometriosis than advanced endometriosis has been reported. However, the pattern of activity in individual colored endometriotic lesions in pelvic cavity is unknown. We investigated the variation in activity of the different colored morphologic lesions as proposed by the current revised American Society of Reproductive Medicine (ASRM) classification in women with endometriosis.
METHODS: Peritoneal fluid (PF) and biopsies were collected during laparoscopy from 45 infertile women with pelvic endometriosis and 15 women without endometriosis. PF concentrations of hepatocyte growth factor (HGF), vascular endothelial growth factor (VEGF), interleukin-6 (IL-6) and monocyte chemotactic protein-1 (MCP-1) were measured by enzyme-linked immunosorbent assay (ELISA). The immunohistochemical staining of HGF and proliferating cell nuclear antigen (PCNA) in opaque and nonopaque endometriotic lesions was examined using respective antibodies, and a computer-analyzed modified quantitative-histogram score (Q-H score) was used to quantify the immunoreaction.
RESULTS: Opaque red lesions were defined as nontransparent lesions, including polypoid excrescence, blood bleb or ecchymosis, and nonopaque lesions were defined as translucent or transparent lesions, including vesicular bleb or clear papule. The women with endometriosis containing dominant opaque red lesions showed significantly higher PF concentrations of HGF, VEGF, IL-6 or MCP-1 than those with either nonopaque lesions or black lesions or control women. There was no difference in any of these cytokine or chemokine levels between women harboring nonopaque lesions and black lesions. Interestingly, PF concentrations of all these markers were significantly reduced in women containing true black lesions and true white lesions after excluding the presence of coexisting red spot from dominant black or white lesions. In a parallel fashion, the immunoexpressions of HGF and PCNA in intact tissue as shown by the Q-H score were significantly stronger in the opaque red lesions than in the nonopaque lesions or black lesions.
CONCLUSIONS: Opaque red lesions display a higher activity than with nonopaque red lesions in both PF and intact tissue. This indicates different histogenesis in their generation in the pelvic cavity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15005786     DOI: 10.1111/j.0001-6349.2004.00229.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  7 in total

1.  Deficiency of immunophilin FKBP52 promotes endometriosis.

Authors:  Yasushi Hirota; Susanne Tranguch; Takiko Daikoku; Akiko Hasegawa; Yutaka Osuga; Yuji Taketani; Sudhansu K Dey
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

2.  Intraoperative detection of subtle endometriosis: a novel paradigm for detection and treatment of pelvic pain associated with the loss of peritoneal integrity.

Authors:  Bruce A Lessey; H Lee Higdon; Sara E Miller; Thomas A Price
Journal:  J Vis Exp       Date:  2012-12-21       Impact factor: 1.355

3.  Circulating and peritoneal fluid interleukin-6 levels and gene expression in pelvic endometriosis.

Authors:  Vânia Teixeira De Andrade; Andréa Prestes Nácul; Betânia Rodrigues Dos Santos; Sheila Bünecker Lecke; Poli Mara Spritzer; Débora Martinho Morsch
Journal:  Exp Ther Med       Date:  2017-07-13       Impact factor: 2.447

4.  VASCULAR ENDOTHELIAL GROWTH FACTOR SERUM LEVELS IN WOMEN WITH ADVANCED ENDOMETRIOSIS.

Authors:  A Malutan; T Drugan; C Georgescu; R Ciortea; C Bucuri; A Bobric; M P Rada; D Mihu
Journal:  Acta Endocrinol (Buchar)       Date:  2016 Jan-Mar       Impact factor: 0.877

5.  Pro-inflammatory cytokines for evaluation of inflammatory status in endometriosis.

Authors:  Andrei M Malutan; Tudor Drugan; Nicolae Costin; Razvan Ciortea; Carmen Bucuri; Maria P Rada; Dan Mihu
Journal:  Cent Eur J Immunol       Date:  2015-04-22       Impact factor: 2.085

Review 6.  Immunological Basis of the Endometriosis: The Complement System as a Potential Therapeutic Target.

Authors:  Chiara Agostinis; Andrea Balduit; Alessandro Mangogna; Gabriella Zito; Federico Romano; Giuseppe Ricci; Uday Kishore; Roberta Bulla
Journal:  Front Immunol       Date:  2021-01-11       Impact factor: 7.561

Review 7.  Bacterial contamination hypothesis: a new concept in endometriosis.

Authors:  Khaleque N Khan; Akira Fujishita; Koichi Hiraki; Michio Kitajima; Masahiro Nakashima; Shinji Fushiki; Jo Kitawaki
Journal:  Reprod Med Biol       Date:  2018-01-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.